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Aminiaturized biotelemetric device for the amperometric
detection of brain tissue oxygen is presented. The new
system, derived from a previous design, has been coupled
with a carbon microsensor for the real-time detection of
dissolved O2 in the striatum of freely moving rats. The
implantable device consists of a single-supply sensor
driver, a current-to-voltage converter, a microcontrol-
ler, and a miniaturized data transmitter. The oxygen
current is converted to a digital value by means of an
analog-to-digital converter integrated in a peripheral
interface controller (PIC). The digital data is sent to a
personal computer using a six-byte packet protocol by
means of a miniaturized 434 MHz amplitude modula-
tion (AM) transmitter. The receiver unit is connected
to a personal computer (PC) via a universal serial bus.
Custom developed software allows the PC to store and
plot received data. The electronics were calibrated and
tested in vitro under different experimental conditions
and exhibited high stability, low power consumption,
and good linear response in the nanoampere current
range. The in vivo results confirmed previously pub-
lished observations on oxygen dynamics in the striatum
of freely moving rats. The system serves as a rapid and
reliable model for studying the effects of different drugs
on brain oxygen and brain blood flow and it is suited
to work with direct-reduction sensors or O2-consuming
biosensors.
Oxygen is the most important oxidative substrate for biochemi-
cal reactions and for the production of ATP in the brain. Tissue
concentration of dissolved O2 is regulated by the balance
between blood supply and local utilization1 and plays a key role
in brain energy metabolism related to either glucose2 or lactate3
used as energy substrates.
The electrochemical reduction of oxygen is a complex process
which can occur on the sensor surface via two mechanisms. In
the first, complete reduction occurs in a single step, without the
formation of detectable intermediates:4
O2+ 4H
++ 4e-f 2H2O (1)
In the second mechanism, reduction of oxygen occurs in two steps





++ 2e-f 2H2O (3)
A wide variety of sensors have been used for direct-reduction
of O2 with the majority of measurements obtained using
constant potential amperometry (CPA) at a noble metal mi-
croelectrode such gold5 or platinum.6 The use of carbon-based
electrodes has been reported by several groups7-9 and often
they are preferred to Pt cathodes because of their in vivo stability
and less surface poisoning.9 Moreover, 10 µm Nafion-coated
carbon fibers, coupled with fast scan voltammetry (FCV), have
been used for the measurement of dissolved oxygen with a
subsecond time resolution.8 However, as previously discussed,9
the ideal sensor size has to be greater than the dimension of blood
capillaries (∼100 µm) for preventing direct blood sampling of
dissolved oxygen. In this article we present a new oxygen sensor
geometry (conical) particularly suited for in vivo applications,
minimizing the tissue trauma related to the stereotaxic implanta-
tion of the sensor in specific brain regions for recording in freely
moving rats.
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In recent years, sophisticated telemetry systems have been
developed for monitoring neurochemicals, such as brain dopam-
ine, in freely moving animals.10,11 However, only a few systems12
have been sufficiently miniaturized and are thus light enough to
be implanted in small rodents. None of these systems have been
designed for the exclusive monitoring of brain oxygen. In this
paper we describe a miniaturized biotelemetric device, specifically
suited to work with O2-reduction sensors, successfully used for
the in situ detection of dissolved oxygen in brain extracellular
fluid (ECF) of freely moving rats. The proposed system can
serve as a rapid and reliable model for studying the effects of
physiological stimulation or different drugs on brain oxygen
and cerebral blood flow.
EXPERIMENTAL SECTION
Reagents and Solutions. All chemicals were analytical
reagent grade, used as supplied, and dissolved in bidistilled
deionized water (MilliQ). Acetazolamide (Sigma, ref A6011),
graphite powder (Fluka, ref 78391) and collodion solution (4%
cellulose nitrate in ethanol/diethyl ether from Fluka, ref 09986)
were purchased from Sigma-Aldrich (Milano, Italy). The phosphate-
buffer saline (PBS) solution was made using NaCl (137 mM), KCl
(2.7 mM), Na2HPO4 (8.1 mM), and KH2PO4 (1.47 mM) from
Sigma, then adjusted to pH 7.4. Ultrapure (>99.9%) oxygen and
nitrogen were purchased from Sapio s.r.l Special Gases Division
(Caponago, Italy). N2-purged and O2-saturated solutions, used
for in vitro calibrations at low concentrations, were prepared
by dissolving (bubbling) the appropriate gas in 10 mL of PBS
for 1 h. The air-saturated solution of PBS (21% O2) was prepared
by bubbling filtered air in 10 mL of PBS for 1 h, using a
diaphragm air pump (DAP). All in vitro calibrations were
performed in freshly prepared N2 and O2 solutions under
standard conditions of pressure and temperature.
Materials and Electronic Parts. Electronic parts and plastic
enclosures were from Farnell-In-One spa (Milano, Italy), the radio
modules were from Telecontrolli spa (TC, Casoria, Italy), and the
USB components were preassembled by Futura Elettronica srl
(Gallarate, Italy). The amperometric section of the biotelemetric
device was built using a dual single-supply operational amplifier
MCP6042 (Arizona Microchip, Chandler) and a ZXRE4001 zener
diode (Zetex, Manchester, U.K.). The analog-to-digital converter
(ADC) was an integral part of the microcontroller (PIC12F683,
Arizona Microchip) used in this system. The 433.92 MHz
amplitude modulation (AM) transmitter was a RT4-433.92 (TC)
while the RR3-433.92 module (TC) was selected as the AM
receiver. Both TC modules were equipped with external antennas.
The serial-to-universal serial bus (USB) converter was a FTDI-
FT232R module with internal E2PROM and integrated clock
synthesizer. All resistors were precision metal oxide thick film
(250 mW, 0.1% tolerance, Ohmite, Rolling Meadows, IL). All
capacitors were NP0-type multilayer ceramic (low pass filter,
decoupling) or electrolytic (decoupling). The components were
soldered on single side printed circuit boards (PCB) produced
as previously described.13,14 Emilac, Positiv, and Plastic technical
sprays were from Cramolin (Mu¨hlacker, Germany). All electronic
parts used in this project were Pb-free and compliant to RoHS
directives. A detailed description of the biotelemetric device,
weighing only 9.6 g, is provided in the Supporting Information.
Animals.Male Sprague-Dawley rats (Morini R. Emilia, Italy),
weighing 280-330 g, were used for in vivo experiments. The rats
were maintained under standard animal care conditions (12 h/12
h light/dark cycle, light at 07.00 h; room temperature 21 °C), with
food and water ad libitum. Prior to the start of any experimental
procedure, the health of the animals was assessed according to
published guidelines.15 All procedures were specifically licensed
under the European Community directive 86/609 included in
Decreto No. 116/1992 of the Italian Ministry of Public Health.
Preparation and Calibration of Oxygen Microsensors. The
O2 microsensors were made using Teflon-insulated silver wires
(30 mm in length; i.d. ) 125 µm, Advent Research Materials,
Suffolk, U.K.) modifying a previously described procedure.16
Approximately 1 mm of the wire was exposed and inserted into
a silica capillary tube (10 mm in length; i.d. ) 180 µm,
Polymicro Technologies, Phoenix, AZ) partly filled with graphite-
loaded (55% w/w) epoxy resin (Araldite-M, Sigma-Aldrich,
Milan, Italy). A preliminary 180 µm diameter carbon-composite
disk electrode (area, 2.5 × 10-4 cm2) was fabricated by mixing
850 mg of graphite with 500 mg of Araldite-M and 200 mg of
harderer16 and filling the silica capillary tubing with the
mixture. The silver wire guaranteed a good electrical contact.
After 24 h at 40 °C, the shape of the working electrode (WE)
was transformed from circular to conical (Figure 1A) using a
high speed drill (Dremel 300) equipped with an aluminum oxide
grinding wheel. The final O2 microsensors had a length ≈ 250
µm, a surface ≈ 1.5 × 10-3 cm2, and a tip <25 µm, dimensions
well below those associated with significant tissue trauma
caused by the implantation of larger probes.17,18 Cellulose nitrate
treatment was performed by immersing the WE in the collodion
solution three times and drying it for 60 min after each coat at 40
°C. O2 reduction was experimentally demonstrated on the
microsensor surface (Figure 1B) starting from -350 mV vs Ag/
AgCl, using cyclic voltammetry (CV37 voltammograph, BAS,
Bioanalytical Systems Inc., West Lafayette) with a scan rate of 25
mV/s. Constant potential amperometry (CPA) was used for in vitro
and in vivo calibrations and experiments, fixing the O2 reduction
potential at -400 mV vs Ag/AgCl reference electrode. No
significant interference signals were observed on exposing the
sensors to other electroactive molecules (ascorbic acid (AA);
uric acid (UA); dopamine (DA); 3,4-dihydroxy-phenylacetic acid
(DOPAC); homovanillic acid (HVA)) present in the striatal
(10) Crespi, F.; Dalessandro, D.; Annovazzi-Lodi, V.; Heidbreder, C.; Norgia,
M. J. Neurosci. Methods 2004, 140, 153–161.
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Methods 2004, 140, 103–115.
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205.
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extracellular fluid, even at pharmacologically relevant concen-
trations (0.5 mM for AA and up to 5 µM for the other
neurochemicals).16
Sensor selection was performed connecting microelectrodes
to a three-electrode system (BAS CV37) and exposing them to
variable O2 concentrations (0%-100%) by means of the ap-
paratus illustrated in Figure 2; only sensors having a O2
sensitivity higher than 200 pA µM-1 were selected (Figure 3A).
A more accurate calibration was performed at low oxygen
concentrations (Figure 3B) connecting the microsensor to the
biotelemetric device (two-electrode system) and adding known
volumes of a standard O2 solution (100%) to nitrogen-saturated
PBS. Only WEs having an O2 detection limit e5 µM were
selected for in vivo implantation. The Ag/AgCl reference/
auxillary (ref/aux) electrode, connected to the biotelemetric
device, was prepared by immersing 1 mm silver wire (i.d. )
125 µm) in a saturated KCl solution and applying +500 mV
for 1 min.
Stereotaxic Surgery and in Vivo Experimental Procedures.
Stereotaxic surgery was performed under chloral hydrate (400
mg kg-1 i.p.) anesthesia. The oxygen microsensor was im-
planted in the right striatum using the following coordinates
from the atlas of Paxinos and Watson:19 A/P +0.5 from the
bregma, +2.5 M/L, and -4.0 D/V from the dura. The ref/aux
electrode was implanted in the left parietal cortex, and two
screws were inserted in the skull for reinforcing the biotele-
metric device adhesion. The “basement” portion of the device
(without battery) was fixed to the skull using dental cement
(Paladur, Heraeus Kulzer, GmbH), and the electrodes were
connected and the skin was sutured (Figure 4A). A “dummy
cover” was coupled to the “basement” to prevent its fouling. Body
temperature during anesthesia was maintained at 37 °C by means
of an isothermal heating pad. After surgery (Figure 4B), the
animals were housed in large plastic bowls (45 cm diameter) and
maintained in a temperature- and light-controlled environment,
with free access to food and water. The O2 microsensor was
polarized 24 h after surgery (day 1) substituting the “dummy
cover” with a “real cover”, after the insertion of the battery in
the “basement”. The oxygen monitoring started with the animal
in its home bowl: this arrangement allowed the rat free
movement (Figure 4C). Following the procedure previously
described in detail,9 mild hyperoxia and hypoxia were induced
on day 1 exposing the rat for 5 min to O2 and N2, respectively.
Acetazolamide was administered i.p. (50 mg kg-1) 48 h after
microsensor implantation (day 2). Physiological stimulations
(tail pinch and induced grooming) were carried out within the
first week after stereotaxic surgery (Figure 4).
Histology. Following the experiments (day 8), rats were
sacrificed with an overdose of chloral hydrate (800 mg kg-1 i.p.).
The location of each oxygen microsensor was confirmed by
postmortem histology. Brains were fixed in formal saline, and
50 mm coronal sections were made with a cryostat. The slices
were stained with cresyl violet and examined under a
microscope.
Statistical Analysis. Concentrations of dissolved O2 were
expressed in micromolar while oxygen reduction current was
expressed in nanoamps and given as baseline-subtracted (Delta
- I) raw data or the mean of 50-1800 consecutive recordings
± standard error of the mean (SEM). The sign of the oxygen
(19) Paxinos, G.; Watson, C. The Rat Brain in Stereotaxic Coordinates, 6th ed.;
Academic Press: San Diego, CA, 2007.
Figure 1. Schematic (A1) and microphotograph (A2) of the conical
oxygen microsensor developed and used in this study and its
electrochemical characterization (B) using cyclic voltammetry (CV).
The conical shape (A2, inset) reduces brain trauma related to the
stereotaxic implantation. CV shows the sensor response to O2, starting
from -350 mV vs Ag/AgCl, similar to that obtained on glassy carbon
electrodes suggestive of two-step O2 reduction (see text).
Figure 2. Drawing of the apparatus for calibrating microsensors
using high O2 concentrations. Pure gas cylinders were connected to
a plastic container enclosing a diaphragm air pump (DAP). During
DAP operation, when a gas cylinder is open, the “air” access serves
as an overpressure valve (output). When the gas cylinders are closed,
the plastic container is rapidly saturated with air (O2 21%). N2 and
O2 cylinders were alternatively opened while DAP transferred the
content of the plastic container in the electrochemical cell (bubbling).
The main aim of this equipment is to obtain a constant gas flow-rate
and a homogeneous electrochemical signal which is independent of
noise from the opening/closing of gas cylinders during gas bubbling.
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currents was inverted for improving the readability of the
plotted data. After in vitro calibrations, the oxygen current was
plotted vs the O2 concentration and the linear regression was
calculated. The changes of brain tissue O2 were calculated as
absolute variations versus the corresponding baseline, and the
oxygen concentrations were estimated (in micromolar) using
pre- and postimplantation in vitro calibrations. The statistical
significance of changes was evaluated using paired t tests
between the means of consecutive recordings before (baseline)
and during the maximum magnitude of oxygen changes as a
resultofphysiologicalstimulationsorpharmacological treatments.
RESULTS
Electronics Test and Calibration. An automated dummy cell
was made based on a previously published design13 for testing
the amperometric module of the biotelemetric device before
sensor calibration. The aim of the design was to devise a Thevenin
current source that would reproduce the constant amperometric
response of a true electrochemical cell. The dummy cell was
assembled connecting five resistors (100, 50, 20, 10, and 6.7 MΩ)
to a multiposition switch and soldering together the resistors’ free
terminals. The voltage applied to the dummy cell was gener-
ated between the WE and the ref/aux electrodes and is equal to
the voltage difference between the above electrodes (-400 mV);
the resulting cathodic currents (-4, -8, -20, -40, and -60 nA)
were converted in an output voltage (VOut) as illustrated in the
Supporting Information. The calibration was made indoors with
a linear distance between the TX and RX units of about 3 m. The
baseline was recorded for 7 consecutive days of continuous
operation, and a 5-point calibration was performed daily. After the
operations described above, a -20 nA current was generated
though the dummy cell by setting the dummy cell resistor to 20
MΩ. The system was left under these conditions until the next
calibration, which was made the following day. A maximum VOut
shift of 5 mV was observed overnight while the current related
to electronic noise was around 20 pA. At the end of the week,
the values of VOut were plotted versus the theorical values of
the correspondent currents (data not shown), and linear
regression was calculated (slope ) -10.13 ± 0.04 mV nA-1; r2
) 0.999; n ) 7). Power consumption results are provided in
the Supporting Information.
Microsensor Response to Oxygen. All in vitro calibrations
were performed 24 h after microsensor manufacture, the same
day of the in vivo implantation (day 0, precalibration), and repeated
8 days later, after the rat sacrifice (day 8, postcalibration). A 10
mL Teflon beaker was modified as described in a previous paper13
and used for calibrations (Figure 2). The sensor response to high
O2 concentrations was tested in quiescent conditions, connect-
ing the WE to a BAS CV37 voltammograph and using the
apparatus and the procedure illustrated in Figures 2 and 3A.
The precalibration (Figure 3A, inset) displayed good linearity with
a slope of 222 ± 17 pA µM-1 of O2 (r2 ) 0.992; n ) 6), while the
postcalibration (data not shown) revealed a small reduction in
linearity and sensitivity (-18%) and an increase in dispersion
(slope ) 183 ± 14 pA µM-1, r2 ) 0.981). Before the calibration
procedure using low O2 concentrations, the oxygen microsen-
sor was connected to the biotelemetry device and placed in
the beaker containing nitrogen-saturated PBS. A constant
potential of -400 mV vs Ag/AgCl was applied, and the
calibration apparatus was placed on a stirrer until a stable
baseline was reached (15 ± 5 nA on day 0 and 12 ± 6 nA on
day 8). A 20 mm diameter magnetic bar was used to mix the
solution after each addition of O2-saturated PBS solution
(Figure 3A), and the O2 reduction current was recorded under
quiescent conditions after stirring. The precalibration (Figure
3B, inset) displayed good linearity with a slope of 255 ± 22 pA
µM-1 of O2 (r2 ) 0.999; n ) 6) while the postcalibration (data
not shown) revealed a reduction in sensitivity comparable with
that previously reported using high O2 concentrations. The
response time of sensors was <1 s. For a detailed description
of the calibration procedures, refer to legends of Figures 2 and
3.
Baseline Levels of Striatal O2. Baseline striatal currents were
recorded daily starting from day 1. The initial microsensor
stabilization was obtained after a period of 47 ± 19 min (n ) 6)
following the activation of the system as previously described. A
total of 30 min of raw data, consisting of 1800 consecutive current
measurements, were recorded in the morning immediately before
physiological or pharmacological testing, averaged, and evaluated
together as mean ± SEM (n) 42). The calculated oxygen baseline
current was 22 ± 4 nA. Considering that the averaged background
current of the microsensor in nitrogen-saturated PBS (days 0 and
8) was around 14 nA, it is possible to estimate the concentration
of O2 using in vitro pre- and postcalibrations; this was found to
Figure 3. In vitro calibrations of oxygen microsensors using high
(A) and low (B) O2 concentrations. Constant potential amperometry
was performed at -400 mV vs Ag/AgCl reference electrode and the
sensors response to O2 was tested by first exposing them to
increasing O2 concentrations (0, 0.2, and 1.25 mM) by means of the
apparatus illustrated in Figure 2. Baseline-subtracted currents (Delta
- I) were recorded in quiescent conditions a few minutes after stopping
the DAP. Only sensors having O2 sensitivity higher than 200 pA µM-1
were selected (panel A, inset). A more accurate calibration (panel B,
inset) was performed at low oxygen concentrations connecting the
microsensor to the biotelemetric device and adding known volumes
(+200, +204, +208, +212, and +216 µL) of a saturated O2 solution
(1.25 mM) to 10 mL of nitrogen-saturated PBS.
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correspond to 37 ± 16 µM, a value consistent with previous
estimates.20-22 Fluctuations in baseline levels were observed day
by day and within the same day, mainly related to the activity of
the rat (data not shown), as reported previously.1,7
Effect of Physiological Stimulation on Striatal O2 Current.
Physiological stimuli, chosen to increase neural activity and
regional cerebral blood flow (rCBF), were administered in the
form of a tail pinch or a water spray. A 5 min tail pinch was applied
to freely moving rats (n ) 6) resulting in the oxygen changes
illustrated in Figure 5A; a few seconds after the paper clip
application we observed an enhancement in motor and chewing
activities (Figure 4D) and a significant increase in striatal O2
current (2.9 ± 0.6 nA, p < 0.05) estimated as +12.4 ± 2.4 µM.
Stimulated water-induced grooming activity (Figure 4E) was
evoked by misting rats with water and resulted in a statistically
significant increase of striatal O2 current compared to the
previous baseline level (2.76 ± 0.31 nA, p < 0.01), as shown in
Figure 5B. The extrapolated increase in O2 concentration was
calculated as 12.0 ± 1.3 µM using in vitro postcalibration curves.
Effect of O2 and N2 Administration on Striatal O2
Current. Pure oxygen and nitrogen were administered to the
rat, housed in its own bowl covered with a 50 cm plexiglas disk,
by connecting the pure gas cylinders directly to the bowl and
opening them alternatively at high fluxes (2 L/min). In this
manner, the gas saturated the bowl in a few seconds and the
animal was forced to breath a mixture of air-O2 or air-N2 for 5
min, as illustrated in Figure 6A. Between O2 and N2 treatments,
the bowl was ventilated for quick removal of gas residuals.
Upon exposure of the animals to pure oxygen, the striatal O2
current promptly increased by +8.5 ± 1.3 nA (+37 ± 6 µM),
(20) Zauner, A.; Bullock, R.; Di, X.; Young, H. F. Neurosurgery 1995, 37, 1168–
1176.
(21) Murr, R.; Berger, S.; Schuerer, L.; Peter, K.; Baethmann, A. Pflugers Arch.
1994, 426, 348–350.
(22) Nair, P. K.; Buerk, D. G.; Halsey, J. H., Jr. Stroke 1987, 18, 616–622.
Figure 4. In vivo experimental procedures for validating the biotelemetric system design. The “basement” portion of the device was fixed to the
skull using dental cement, (A) and a “dummy cover” (B) was coupled to the “basement” to prevent its fouling. Following surgery, the animals
were housed in large plastic bowls and maintained in a temperature- and light-controlled environment, with free access to food and water (C).
The oxygen monitoring started 24 h after surgery. Pharmacological treatments and physiological stimulations such as tail pinch (D) and induced
grooming (E) were carried out within the first week after stereotaxic surgery.
Figure 5. Effect of physiological stimulation on striatal dissolved
oxygen. A 5 min tail pinch was applied to freely moving rats (A) resulting
in an enhancement in motor and chewing activities observed a few
seconds after the paper clip application with a concomitant increase in
striatal O2 current (+2.9 ( 0.6 nA, *, p < 0.05 vs baseline). Induced
grooming (B) was evoked by misting rats with water and resulted in a
statistically significant increase of striatal O2 signal (+2.76 ( 0.31 nA, *,
p < 0.01 vs baseline). Delta - I, baseline-subtracted current.
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returning to baseline immediately after O2 removal. In contrast,
the exposure to nitrogen induced a short-lasting decline of the
striatal oxygen signal (-5.8 ± 1.0 nA), estimated as -23 ± 4
µM from the baseline. Both striatal changes were statistically
different from the baseline (Figure 6A, top-right inset; *, p <
0.05).
Effect of Systemic Acetazolamide Administration on Stri-
atal O2 Current. The carbonic anhydrase inhibitor acetazolamide
(Diamox) is a drug that induces a rise in brain oxygen.23 The
drug was dissolved in 1.5 mL of saline and administered i. p. at
the dose of 50 mg kg-1. An increase in striatal O2 current was
observed during the first minutes after acetazolamide admin-
istration (Figure 6B) and remained high for several hours. The
maximum oxygen variation vs baseline (*, p < 0.05) was achieved
20-40 min after the drug injection with an increase of +5.7 ± 0.7
nA, corresponding to + 25 ± 3 µM of O2. A control group of
animals received only saline (data not shown) resulting in a
short-lasting increase of striatal oxygen, in agreement with
previously published observations related to mild stress.9
DISCUSSION
Principles of Operation and Performance of the Biotele-
metric Device. The analog circuitry of the biotelemetric device
was optimized for single-supply, low-voltage operation, using a
single stage of amplification and reducing the number of electronic
components. The amperometric module is build around Vz, a fixed
voltage (1.22 V) generated by an ultralow-power zener diode.
Vref/aux was directly connected to Vz while the WE was stabilized
to 820 mV (-400 mV vs Vz) by means of a buffered voltage
divider. As shown in the Supporting Information (Figure S-1A),
fixing Rf to 10 MΩ, OPA2 converted the input reduction current
to VOut with an amplification factor of 100 nA/V. In this manner
we successfully overcame the limitations of the previous
design,13,14 related to variations in the resistor values, mainly in
the difference circuit. In fact we completely suppress the differ-
entiator by transferring to firmware the VApp-subtraction previ-
ously implemented by hardware. The ADC input of the
microcontroller was directly wired to VOut and the ADC
reference connected to Vz. This means that VOut was digitized
in a range between 0 and 1.22 V with an oversampled resolution
of 14 bits (corresponding to 16 384 least significant bits (LSBs).
The digital value 11012 corresponds to 820 mV (0 nA) while
5640 to 420 mV (-40 nA) and so on. The micro controller unit
(MCU) performed the specific conversion for obtaining the
current values (inverted in sign) and transmitted them to the
receiver. VApp could be modified by changing the values of R1
and R2 (Supporting Information, Figure S-1A) or substituting
them with a trimmer potentiometer; in this case it is important to
consider that lowering VApp reduces the range of the input
current. The input current range could be (re)extended
decreasing the value of Rf. The main advantage of the described
electronics is that Vz and VApp are independent from the voltage
drop related to battery discharge. The result is that the module
is characterized by gain precision, stability, and an excellent
linear response. The system can operate only in reduction
mode, and it is particularly suited to work with direct-reduction
sensors, such oxygen microsensors, or O2-consuming biosen-
sors based on oxidase enzymes.24 The power consumption
lower than 400 µW guarantees a long battery life. The
biotelemetric system was interfaced to the software via USB
with the possibility of high-level access to the received packets.
This means that further data handling could be done by means
of widely used software packages such as LabView or Dasylab.
All experiments were made indoor, in a linear range comprised
between 0 and 3 m, without communication problems. The
weight of the implantable biotelemetry unit is compatible with
similar commercial devices,12 represents ∼3% of the rat body
weight, and it is well tolerated by the animals in agreement
with other studies.25 The operation of several biotelemetric
systems, operating in the same room, was tested after reduction
of the transmission distance by varying the antenna tuning and
modifying the “synch” byte of the transmission packet.
Performance of the Oxygen Microsensor. Oxygen mi-
crosensors were developed using an original procedure for
obtaining carbon-epoxy cone electrodes optimized for in vivo
applications. The conical shape reduces tissue trauma related to
the stereotaxic implantation in the striatum while the size, ranging
from ∼25 (cone tip) to 180 µm (cone base), guarantees oxygen
detection in brain tissue and not in small blood vessels as reported
for carbon fibers.9 The electrode surfaced was coated with
(23) Rivera-Ch, M.; Huicho, L.; Bouchet, P.; Richalet, J. P.; Leon-Velarde, F.
Respir. Physiol. Neurobiol. 2008, 162, 184–189.
(24) Wu, L.; Zhang, X.; Ju, H. Biosens. Bioelectron. 2007, 23, 479–484.
(25) Leon, L. R.; Walker, L. D.; DuBose, D. A.; Stephenson, L. A. Am. J. Physiol.
Regul. Integr. Comp. Physiol. 2004, 286, R967–974.
Figure 6. Effect of pharmacological treatments on striatal dissolved
oxygen. Exposing the animal to pure oxygen (A), the striatal O2 current
promptly increased by +8.5 ( 1.3 nA (*, p < 0.01 vs baseline)
returning-back to baseline immediately after O2 removal. On the
contrary, the exposure to nitrogen (A) induced a short-lasting decline
of the striatal oxygen signal (-5.8 ( 1.0 nA; #, p < 0.01 vs baseline).
Acetazolamide, a carbonic anhydrase inhibitor, was administered i.
p. at the dosage of 50 mg kg-1. An increase of striatal O2 current
was observed during the first minutes after acetazolamide administra-
tion (B) and remained high for several hours. The maximum oxygen
variation vs baseline (+5.7 ( 0.7 nA; *, p < 0.05) was achieved
20-40 min after the drug injection. Delta - I, baseline-subtracted
current.
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nitrocellulose (collodion) using a protocol previously described
by Dittmar and co-workers26 for making O2 microsensors.
Collodion is a highly hydrophobic cellulose-based membrane.
Small charged molecules (ions) and gases (O2) can permeate
the membrane which acts as a barrier for bigger organic
molecules such as proteins, reducing a possible poisoning of
the WE surface.26 The oxygen microsensor characteristics were
evaluated up to 1 week in vitro, showing good accuracy and
precision. Cyclic voltammetry, performed at pH 7.4, showed
sensor response to O2 similar to that obtained by other research
groups on glassy carbon electrodes24,27 suggestive of a two-step
O2 reduction.28 The in vivo drop in sensitivity (∼-18% after 7
days of implantation in the striatum) was higher than the in
vitro decrease measured at the same time (∼-11%, data not
shown), confirming a mild fouling process of the sensor surface
despite the collodion coating. As detailed in the Experimental
Section and Results sections, quiescent calibrations, performed
using low and high O2 concentrations at different times, were
used to estimate oxygen concentration in vivo. Further studies
are necessary for evaluating the long-term response of sensors
to oxygen in vitro and in vivo and the sensor aging process.
Striatal Oxygen Changes after Physiological Stimulations
and Pharmacological Treatments. Several authors1,9,29-31 re-
ported that basal oxygen concentration, recorded in the extracel-
lular space of the striatum, is relatively low (∼50 µM); these
observations are in agreement with the findings of the present
study. Striatal oxygen dynamics, following physiological stimula-
tions, resulted in a rise in the local O2 signal. This result seems
to be in opposition with the fact that during neural activation
we would expect an increase of oxygen consumption and a
consequential decrease in its extracellular concentration.
However, O2 tissue concentration is regulated by the balance
between blood supply and local utilization.1,9 In agreement with
previous reports,1,9 during neural activation the increase in rCBF
is greater than local utilization. These findings indicate that, under
physiological stimulations, local O2 changes can be used as an
index of rCBF but only when the oxygen supply significantly
exceeds its utilization.1,9 Direct-administration of O2 (or N2) to
a freely moving rat produced mild hyperoxia (or hypoxia) and
resulted in an immediate and significant increase (or decrease)
of the oxygen signal until the pure gas was substituted with
air. This evidence indicates both the fast response time of O2
microsensors and the immediate transport of inhaled gases to
the brain and confirmed previous studies on “wired” awake
rats.9
Systemic administration of acetazolamide induced a sustained
increase of striatal oxygen, confirming previous results obtained
using carbon paste O2 sensors in freely moving rats.9,31 Aceta-
zolamide (Diamox) is a carbonic anhydrase inhibitor that prevents
the conversion of CO2 and H2O in H2CO3 and H+. In addition,
acetazolamide forces the kidneys to eliminate H2CO3 with the
concomitant acidification of the blood. The accumulation of CO2
in the organism induces hyperventilation and an increase in
brain oxygen concentration; for this reason acetazolamide is
the most used drug for altitude sickness prevention and
treatment.23
CONCLUSIONS
In this study we present a novel biotelemetric device for the
real-time detection of brain oxygen in freely moving rats. The
transmitter and the receiver units can be used for accurate
transduction of the cathodic currents generated on the surface of
O2 microsensors. This implantable device consists of two parts
that, when assembled, polarize the sensor and send oxygen-
reduction data to a receiving unit connected to a PC. The
systems electronics were tested under different experimental
conditions exhibiting low power consumption, high stability,
and good linear response. The in vivo results confirmed
previously published observations on striatal oxygen dynamics.
This apparatus, based on simple and inexpensive components,
could be used as a rapid and reliable model for studying the
effects of different drugs on brain oxygen dynamics.
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